1
|
Allameh F, Hasanzadeh Haddad A, Abedi A, Ranjbar A, Qashqai H, Fadavi B, Yousefi M. Varicocelectomy with primary gubernaculum veins closure: A randomised clinical trial. Andrologia 2018; 50:e12991. [PMID: 29460294 DOI: 10.1111/and.12991] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/18/2018] [Indexed: 11/30/2022] Open
Abstract
To evaluate the effect of microsurgical inguinal varicocelectomy with testicular delivery on semen parameters. A total of 416 patients, diagnosed with grade III varicocele, were randomised into two groups. One group underwent microsurgical inguinal varicocelectomy without testicular delivery. For the other group, testicular delivery and ligation of gubernacular and all collateral veins were performed. A semen analysis was performed before and 6 months after the procedure. Mean age of the patients in the case and control groups was 27.3 ± 6.1 years and 25.9 ± 4.6 years respectively (p = .1). The total number of recurrence after 6 months in the conventional and testicular delivery groups was 13 (6.5%) and 3 (1.5%) (p < .05). No case of hydrocele formation was observed in any of the groups. All sperm parameters were improved 6 months after the surgery in both groups. But comparing the mean improved difference between the two groups revealed a significant difference in improvement in sperm motility for patients who had undergone varicocelectomy with testicular delivery (p = .05). Microsurgical inguinal varicocelectomy is a safe and efficient technique with a minimum chance of post-operative complications and recurrence and also may have role in improvement of sperm motility compared with conventional techniques.
Collapse
Affiliation(s)
- F Allameh
- Clinical Research Development Unit, Shohada-e-Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - A Hasanzadeh Haddad
- Urology Department, Shohada-e-Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - A Abedi
- Urology Department, Shohada-e-Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - A Ranjbar
- Urology Department, Shohada-e-Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - H Qashqai
- Urology Department, Shohada-e-Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - B Fadavi
- Urology Department, Shohada-e-Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - M Yousefi
- Urology Department, Shohada-e-Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| |
Collapse
|
2
|
Mehrsai AR, Namdari F, Salavati A, Dehghani S, Allameh F, Pourmand G. Comparison of transdermal electromotive administration of verapamil and dexamethasone versus intra-lesional injection for Peyronie's disease. Andrology 2012; 1:129-32. [DOI: 10.1111/j.2047-2927.2012.00018.x] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2012] [Revised: 08/15/2012] [Accepted: 08/20/2012] [Indexed: 11/28/2022]
Affiliation(s)
- A. R. Mehrsai
- Urology Research Center; Tehran University of Medical Sciences; Tehran; Iran
| | - F. Namdari
- Urology Research Center; Tehran University of Medical Sciences; Tehran; Iran
| | - A. Salavati
- Urology Research Center; Tehran University of Medical Sciences; Tehran; Iran
| | - S. Dehghani
- Urology Research Center; Tehran University of Medical Sciences; Tehran; Iran
| | - F. Allameh
- Urology Research Center; Tehran University of Medical Sciences; Tehran; Iran
| | - G. Pourmand
- Urology Research Center; Tehran University of Medical Sciences; Tehran; Iran
| |
Collapse
|
3
|
Pourmand G, Ramezani R, Sabahgoulian B, Nadali F, Mehrsai AR, Nikoobakht MR, Allameh F, Hossieni SH, Seraji A, Rezai M, Haidari F, Dehghani S, Razmandeh R, Pourmand B. Preventing Unnecessary Invasive Cancer-Diagnostic Tests: Changing the Cut-off Points. Iran J Public Health 2012; 41:47-52. [PMID: 23113134 PMCID: PMC3481674] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/11/2011] [Accepted: 12/12/2011] [Indexed: 12/02/2022]
Abstract
BACKGROUND To determine a cut-off point of tPSA and PSAD to prevent unnecessary invasive cancer-diagnosing tests in the community. METHODS This study was performed on 688 consecutive patients referred to our center due to prostatism, suspicious lesions on digital rectal examination and/or elevated serum PSA levels. All patients underwent transrectal ultrasound guided biopsies and obtained PSAD. Serum levels of tPSA and fPSA were measured by chemiluminescence. Comparisons were done using tests of accuracy (AUC-ROC). RESULTS Prostate cancer was detected in 334 patients, whereas the other 354 patients were suffering from benign prostate diseases. The mean tPSA in case and control groups were 28.32±63.62 ng/ml and 7.14±10.04 ng/ml; the mean f/tPSA ratios were 0.13± 0.21 and 0.26±0.24 in PCa and benign prostate disease groups; the mean PSAD rates were 0.69±2.24, 0.12±0.11, respectively. Statistically significant differences were found (P <0.05). Using ROC curve analysis, it was revealed that AUC was 0.78 for tPSA and 0.80 for f/tPSA. Sensitivity was 71% for the cut-off value of 7.85ng/ml. For f/tPSA ratio, the optimal cut-off value was 0.13 which produced the sensitivity of 81.4% and for PSAD, it was15%. CONCLUSIONS As this trial is different from the European and American values, we should be more cautious in dealing with the prostate cancer upon the obtained sensitivity and specificity for PCa diagnosis (7.85ng/mL for tPSA, 15% for PSAD and 0.13 for f/tPSA ratio).
Collapse
Affiliation(s)
- G Pourmand
- Urology Research Center, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran,Corresponding Author: Fax: +9821 6634 8561, E-mail address:
| | - R Ramezani
- CDC Cancer Office, Ministry of Health and Medical Education, Tehran, Iran
| | | | - F Nadali
- Dept. of Hematology, Allied Health Medicine, Tehran University of Medical Sciences, Tehran, Iran
| | - AR Mehrsai
- Urology Research Center, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
| | - MR Nikoobakht
- Urology Research Center, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
| | - F Allameh
- Urology Research Center, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
| | - SH Hossieni
- Urology Research Center, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
| | - A Seraji
- Urology Research Center, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
| | - M Rezai
- Bistoon Ultrasound Clinic, Tehran, Iran
| | - F Haidari
- Urology Research Center, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
| | - S Dehghani
- Urology Research Center, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
| | - R Razmandeh
- Urology Research Center, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
| | - B Pourmand
- Research Development Center, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
| |
Collapse
|
4
|
Pourmand G, Salem S, Hosseini M, Allameh F, Mehrsai A. UP-02.095 Serum Calcium as a Protective Marker Against Prostate Cancer: Role of Associated Factors. Urology 2011. [DOI: 10.1016/j.urology.2011.07.913] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|